Oser Communications Group


Issue link: http://osercommunicationsgroup.uberflip.com/i/1153031

Contents of this Issue


Page 3 of 55

Chain Drugstore Daily Sunday, August 25, 2019 4 Retail Pharmacies Need to Be Ready for Rx Recalls By Kirk Herweck, Director, Rx Supply Chain & Workplace Solutions, Inmar Recalls for pharmaceuticals are a con- cern, a challenge – and a cost center – for everyone in the Rx value chain. Therefore, retail pharmacies cannot rely solely on suppliers to notify them regard- ing recalls and/or product withdrawals. To improve their response to market actions, retail pharmacies need to opti- mize the recall notification function and reduce their recall alert processing time. That's why retail pharmacies need RASMAS. RASMAS is an automated product recall notification, communica- tion disbursement and reporting tool available from Inmar that streamlines the Rx recall response workflow and helps ensure proper recall management and documentation. With RASMAS in place, retail pharmacies can reduce their recall alert processing time by as much as 80 percent. A "Noisy" Recall Environment As the industry is experiencing a record number of Rx recalls, the challenges to immediate and effective response are increasing. Compounding the system- wide stress created by this increased activity is the tremendous "noise" gen- erated by multiple sources distributing redundant and duplicate recall notices, often in multiple and vary- ing formats. The resulting effects from all of this include misdirection of recall notifica- tions, a lack of accountability and visibil- ity throughout individual retail organiza- tions during a recall response and poten- tial liability for mismanagement of recall response due to lack of consolidated Aurobindo: Organic Growth, Strategic Acquisitions Aurobindo Pharma Limited (APL) was incorporated on the 26th of December 1986 as a private limited company by Mr. P.V. Ramprasad Reddy and Mr. K. Nityananda Reddy. Born of their vision and a relatively small group of highly committed scientists, engineers and pro- fessionals, the company commenced operations with a single manufacturing unit, specializing in semi-synthetic peni- cillin (SSP). Roughly two years later, another manufacturing unit was estab- lished near Hyderabad, India. The addi- tion of this manufacturing unit empha- sized Aurobindo's focus on its core strengths of vertical integration, large scale manufacturing and a robust R&D portfolio. In 1992, Aurobindo Pharmaceutical Limited became a public company, and by 1995 it listed on the Indian Stock Exchange. Ten years later it made a strategic move to enter the premium mar- kets of the USA and Europe with its generic formulations. Aurobindo Pharma Limited exports to over 150 countries across the globe. Today, Aurobindo Pharma USA, Inc. operates as a wholly owned U.S. subsidiary of Aurobindo Pharma Limited with headquarters in East Windsor, New Jersey. The company has successfully launched affordable products across mul- tiple therapeutic areas and delivery tech- nologies while leveraging world-class talent in a global market. Aurobindo has managed to grow its business rapidly, both organically and by way of strategic acquisitions, to be one of the leading companies in the industry. The company has received among the highest number of ANDA approvals of all generic firms Continued on Page 53 Continued on Page 53 AN INDEPENDENT PUBLICATION NOT AFFILIATED WITH NACDS Kimberly Oser Publisher Jules Denton-Card Senior Associate Publisher Lorrie Baumann Editorial Director Anthony Socci Associate Publisher Jeanie Catron • JoEllen Lowry • Karrie Welborn Associate Editors Yasmine Brown Art Director Jonathan Schieffer Graphic Designer Susan Stein Customer Service Manager Marcos Morhaim Senior Account Manager Tara Neal Director of Operations Jay Watson • Hannah Stefanovich Show Logistics & Distribution Enrico Cecchi European Sales Chain Drugstore Daily is published by Oser Communications Group ©2019 All rights reserved. Executive and editorial offices at: 1877 N. Kolb Road, Tucson, AZ 85715 520.721.1300/Fax: 520.721.6300 European offices located at Lungarno Benvenuto Cellini, 11, 50125 Florence, Italy www.osercommunicationsgroup.com Lee M. Oser Founder

Articles in this issue

Links on this page

view archives of Oser Communications Group - NACDS.TSE19.Aug25